Sevoflurane is a sweet-smelling, nonflammable, highly fluorinated methyl isopropyl ether used as an inhalational anaesthetic for induction and maintenance of general anesthesia. After desflurane, it is the volatile anesthetic with the fastest onset and offset.
Isoflurane is a general anesthetic. It can be used to start or maintain anesthesia. Often another medication is used to start anesthesia due to airway irritation with isoflurane. It is used by inhalation.
Desflurane is a highly fluorinated methyl ethyl ether used for maintenance of general anesthesia. Like halothane, enflurane, and isoflurane, it is a racemic mixture of (R) and (S) optical isomers (enantiomers). Together with sevoflurane, it is gradually replacing isoflurane for human use, except in economically undeveloped areas, where its high cost precludes its use. It has the most rapid onset and offset of the volatile anesthetic drugs used for general anesthesia due to its low solubility in blood.
Increasing prevalence of cardiovascular and respiratory diseases and population growth are expected to fuel the market. The large amount of evoflurane, isoflurane and desflurane need to be used to help patients reduce pain. Cataract surgery is a major contributor to the global market. A major factor hindering the market is the quantity of CO2 released in the environment, leading to global warming. The United States occupies the biggest share in the worldwide inhalation anesthesia market in 2014. Asia Pacific will experience the fastest growth owing to the rise of chronic diseases and demand for better health infrastructure in the region.
Global Sevoflurane, Isoflurane and Desflurane market size will increase to xx Million US$ by 2025, from xx Million US$ in 2018, at a CAGR of xx% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Sevoflurane, Isoflurane and Desflurane.
This report researches the worldwide Sevoflurane, Isoflurane and Desflurane market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global Sevoflurane, Isoflurane and Desflurane breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
The following manufacturers are covered in this report:
AbbVie
Baxter
Lunan Pharmaceutical Group
Sevoflurane, Isoflurane and Desflurane Breakdown Data by Type
Sevoflurane
Isoflurane
Desflurane
Sevoflurane, Isoflurane and Desflurane Breakdown Data by Application
Cardiovascular Diseases
Respiratory Diseases
Cancer Diseases
Orthopedic Diseases
Spinal Diseases
Gastro-Intestinal Diseases
Sevoflurane, Isoflurane and Desflurane Production Breakdown Data by Region
United States
Europe
China
Japan
Other Regions
Sevoflurane, Isoflurane and Desflurane Consumption Breakdown Data by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Russia
Rest of Europe
Central & South America
Brazil
Rest of South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Rest of Middle East & Africa
The study objectives are:
To analyze and research the global Sevoflurane, Isoflurane and Desflurane capacity, production, value, consumption, status and forecast;
To focus on the key Sevoflurane, Isoflurane and Desflurane manufacturers and study the capacity, production, value, market share and development plans in next few years.
To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Sevoflurane, Isoflurane and Desflurane :
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Summary:
Get latest Market Research Reports on Sevoflurane, Isoflurane and Desflurane . Industry analysis & Market Report on Sevoflurane, Isoflurane and Desflurane is a syndicated market report, published as Global Sevoflurane, Isoflurane and Desflurane Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Sevoflurane, Isoflurane and Desflurane market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.